Results 261 to 270 of about 49,358 (274)

Cutaneous Leishmaniasis in an Infant

Pediatric Dermatology, 1983
Abstract: Cutaneous leishmaniasis (CL) in the United States is unusual. We report an infant who developed CL after returning from an endemic area. A skin biopsy yielded Leishmania organisms within 48 hours. The cutaneous lesions resolved with scarring after several months.
James Longabaugh, Paul W. Orton, Loren E. Golitz, J. Joseph Marr, William L. Weston, Barbara R. Reed   +5 more
openaire   +3 more sources

Cutaneous leishmaniasis in Niger

The American Journal of Tropical Medicine and Hygiene, 1990
This is the first report of cutaneous leishmaniasis in Niger subsequent to the initial finding in 1911 and the report of a second case in 1943. The clinical, histopathological, and epidemiological features of 64 parasitologically confirmed cases are described. Lesions were mostly multiple, situated on exposed areas of skin, but rarely on the face.
M. Develoux, Andre Warter, Harouna Djingarey Mamoudou, Leopold Blanc, Soga Garba, Pierre Ravisse   +5 more
openaire   +3 more sources

Epidemiology of cutaneous leishmaniasis

Clinics in Dermatology, 1999
Leishmaniasis refers to an infection caused by protozoan parasites of the genus Leishmania. Of the three clinical expressions of the disease—cutaneous, visceral, and mucocutaneous—the cutaneous form (CL) is the most abundant. It is important to recognize that CL does not refer to a single disease.
Arieh Ingber, Sidney Klaus, Shoshana Frankenburg   +2 more
openaire   +3 more sources

Cutaneous leishmaniasis treatment

Travel Medicine and Infectious Disease, 2007
The causative species of cutaneous leishmaniasis determines the clinical features and courses, and treatments. Intralesional or systemic antimonials are the gold standard for the treatment of these diseases. However, as for visceral leishmaniasis, other therapeutic options appear promising.
Philippe Minodier, Philippe Parola
openaire   +3 more sources

Cutaneous and Mucocutaneous Leishmaniasis

Infectious Disease Clinics of North America, 2012
Tegumentary leishmaniases are caused by approximately 15 species of protozoa of the genus Leishmania. They prevail in tropical and subtropical areas of the Old and New World but human mobility also makes them a medical problem in nonendemic areas. Clinical manifestations may comprise cutaneous and mucocutaneous forms that may be localized, disseminated,
Hiro Goto, José Angelo Lauletta Lindoso
openaire   +3 more sources

Cutaneous Leishmaniasis

New England Journal of Medicine, 2020
Alexia P, Knapp, Jonathan D, Alpern
openaire   +2 more sources

Management of cutaneous leishmaniasis

Current Opinion in Infectious Diseases, 2001
There is an urgent need for a safe, effective, easily administered and cheap treatment for cutaneous leishmaniasis. Unfortunately it remains elusive. There have been a number of contributions during the last year, but none will change present day management.
openaire   +3 more sources

Cutaneous Leishmaniasis

JAMA: The Journal of the American Medical Association, 1963
W M, FRASER, R G, FREEMAN, D A, DREYER, J M, KNOX   +3 more
openaire   +2 more sources

Cutaneous Leishmaniasis

International Journal of Dermatology, 1979
openaire   +4 more sources

Psoriasiform cutaneous leishmaniasis

International Journal of Dermatology, 2006
S. Veraldi, C. Galloni, R. Cremonesi, R. Cavalli   +3 more
openaire   +3 more sources